Dongwha Pharm Acquires Hironic, Enters ... > 경제기사 | economics

[Alpha Biz= Reporter Kim Jisun] Dongwha Pharm announced on the 9th that it has decided to acquire shares in Hironic, a company specializing in aesthetic medical devices. The acquisition deal is valued at 160 billion KRW, with Mirae Asset Venture Investment PE also planning to co-invest. Following the signing of the contract on the 6th, Dongwha Pharm expects to complete the transaction by December after due diligence.

Hironic develops, manufactures, and sells advanced skin care devices based on high-intensity focused ultrasound HIFU and radio frequency RF technologies. The company offers a global range of products, including both hospital-grade and personal aesthetic devices.


The aesthetic medical device industry, driven by advancements in technology, is creating a new paradigm by replacing traditional plastic surgeries with non-invasive procedures like skin lifting, tightening, and fat reduction. The sector is expected to show strong growth potential in the future.

관련기사

▶ HMM Forms New Premier Alliance with ONE and Yang Ming, Replacing THE Alliance

▶ Coupang Files Administrative Lawsuit Against KRW 162.8 Billion Fine from Fair Trade Commission

▶ EcoPro and GEM to Launch Integrated Cathode Materials Business in Indonesia

▶ Union of Incheon International Airport Subsidiaries to Strike During Chuseok Holiday Over Poor Working Conditions

▶ Kia Reaches Tentative Wage and Collective Agreement Without Disputes for 4th Consecutive Year

/ 알파경제 Kim Jisun Reporter